| Study Number |
Title |
| 8980 |
Tissue Procurement and Laboratory Core
|
| 15410A |
Utilization of Previously Banked Tissues from Patients with Head and Neck and Lung Cancer for Analysis of DNA repair markers and Correlation With Clinical Data
|
| 09-266-B |
Randomized Phase II Trial of Everolimus versus Placebo as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)
|
| 16998A |
Chart Investigation of Patients with Oral Cavity Cancer
|
| 10-540-B |
Observational Study of Swallowing Function after Treatment of Advanced Laryngeal Cancer
|
| 10-652-B |
Vorinostat and Carboplatin in Patients with Advanced Solid Tumors: A Pharmacokinetic and Pharmacodynamic Study
|
| 11-0032 |
A Pilot Feasibility Study of 99mTc EC DG SPECT/CT Imaging in the Treatment Response Evaluation in Patients with Locally Advanced Head and Neck Cancer
|
| 11-0265 |
Randomized Placebo- Controlled Phase II Study of ZD6474 as a Chemopreventive Agent for Premalignant Lesion of the Head and Neck
|
| 11-0719 |
AN OPEN-LABEL, PHASE I, DOSE-ESCALATION STUDY EVALUATING THE SAFETY AND TOLERABILITY OF GDC-0980 ADMINISTERED ONCE DAILY IN PATIENTS WITH REFRACTORY SOLID TUMORS OR NON-HODGKIN�S LYMPHOMA
|
| 12-1208 |
RTOG 1016: Phase III Trial of Radiotherapy Plus Cetuximab Versus Chemoradiotherapy in HPV-Associated Oropharynx Cancer
|
| 12-1554 |
Nab-Paclitaxel-based re-induction chemotherapy followed by response-stratified chemoradiotherapy in patients with previously treated squamous cell carcinoma of the head and neck.
|
| 12-1712 |
A091101: TPF Induction Chemotherapy and ABT-888 (Veliparib) - a Phase 1/Randomized Phase 2 Study in Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck
|
| 13-0311 |
A Phase Ib Multi-Cohort Study of MK-3475 in Subjects with Advanced Solid Tumors
|
Bone